YAP/TAZ Signaling in the Pathobiology of Pulmonary Fibrosis
Open Access
Abstract
Pulmonary fibrosis (PF) is a severe, irreversible lung disease characterized by progressive scarring, with idiopathic pulmonary fibrosis (IPF) being the most prevalent form. IPF’s pathogenesis involves repetitive lung epithelial injury leading to fibroblast activation and excessive extracellular matrix (ECM) deposition. The prognosis for IPF is poor, with limited therapeutic options like nintedanib and pirfenidone offering only modest benefits. Emerging research highlights the dysregulation of the yes-associated protein (YAP)/transcriptional coactivator with PDZ-binding motif (TAZ) signaling pathway as a critical factor in PF. YAP and TAZ, components of the Hippo pathway, play significant roles in cell proliferation, differentiation, and fibrosis by modulating gene expression through interactions with TEA domain (TEAD) transcription factors. The aberrant activation of YAP/TAZ in lung tissue promotes fibroblast activation and ECM accumulation. Targeting the YAP/TAZ pathway offers a promising therapeutic avenue. Preclinical studies have identified potential treatments, such as trigonelline, dopamine receptor D1 (DRD1) agonists, and statins, which inhibit YAP/TAZ activity and demonstrate antifibrotic effects. These findings underscore the importance of YAP/TAZ in PF pathogenesis and the potential of novel therapies aimed at this pathway, suggesting a new direction for improving IPF treatment outcomes. Further research is needed to validate these approaches and translate them into clinical practice.Keywords
This publication has 88 references indexed in Scilit:
- Eggshell membrane and its major component lysozyme and ovotransferrin enhance the secretion of decorin as an endogenous antifibrotic mediator from lung fibroblasts and ameliorate bleomycin-induced pulmonary fibrosisBiochemistry and Biophysics Reports, 2024
- Icariin attenuates bleomycin-induced pulmonary fibrosis by targeting Hippo/YAP pathwayBiomedicine & Pharmacotherapy, 2021
- YAP mediates the interaction between the Hippo and PI3K/Akt pathways in mesangial cell proliferation in diabetic nephropathyActa Diabetologica, 2020
- YAP/TAZ affects the development of pulmonary fibrosis by regulating multiple signaling pathwaysMolecular and Cellular Biochemistry, 2020
- Targeted therapies in systemic sclerosis, myositis, antiphospholipid syndrome, and Sjögren's syndromeBest Practice & Research Clinical Rheumatology, 2020
- Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patientsLung, 2019
- Icariin inhibits chondrocyte apoptosis and angiogenesis by regulating the TDP‐43 signaling pathwayMolecular Genetics & Genomic Medicine, 2019
- Trigonelline and related nicotinic acid metabolites: occurrence, biosynthesis, taxonomic considerations, and their roles in planta and in human healthPhytochemistry Reviews, 2014
- Inhibition of Wnt/β‐Catenin Signaling Promotes Engraftment of Mesenchymal Stem Cells to Repair Lung InjuryJournal of Cellular Physiology, 2013
- PAI‐1 in tissue fibrosisJournal of Cellular Physiology, 2011